Ford David A Insider Trades

Insider Trading History

Track insider trading activity for Ford David A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Prothena plc
Prothena plc PRTA
Chief People Officer
Holding Value $959k 107,500 shares
Last Trade
Mar 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.61M 107,500 shares
$14.95
$8.92
Prothena plc
Prothena plc PRTA
Chief People Officer
Holding Value $758k 85,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.43M 85,000 shares
$28.53
$8.92
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $0 0 shares
Last Trade
Nov 08, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.64M 86,323 shares
$19.00
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $0 0 shares
Last Trade
Nov 08, 2023 Sale (Tender)Reported as Tender on SEC Form 4.
$286k 15,038 shares
$19.00
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $692k 36,438 shares
Last Trade
Jan 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$294k 16,000 shares
$18.40
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $506k 26,638 shares
Last Trade
Dec 31, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$22k 1,777 shares
$12.37
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $540k 28,415 shares
Last Trade
Jan 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$163k 11,300 shares
$14.44
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $414k 21,815 shares
Last Trade
Jan 01, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.73k 106 shares
$16.29
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $416k 21,921 shares
Last Trade
Dec 31, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$26.2k 1,606 shares
$16.29
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $447k 23,527 shares
Last Trade
Oct 01, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.4k 92 shares
$15.22
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $449k 23,619 shares
Last Trade
Jul 01, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.88k 92 shares
$20.47
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $451k 23,711 shares
Last Trade
May 08, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.2k 128 shares
$17.15
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $453k 23,839 shares
Last Trade
Apr 01, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.23k 92 shares
$24.28
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $455k 23,931 shares
Last Trade
Feb 08, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.33k 148 shares
$36.04
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $458k 24,079 shares
Last Trade
Jan 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$530k 18,000 shares
$29.46
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $239k 12,579 shares
Last Trade
Jan 01, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.62k 106 shares
$24.70
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $241k 12,685 shares
Last Trade
Dec 31, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15.5k 629 shares
$24.70
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $253k 13,314 shares
Last Trade
Nov 08, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.6k 128 shares
$28.15
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $255k 13,442 shares
Last Trade
Oct 01, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.87k 92 shares
$42.08
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
Chief Human Resources Officer
Holding Value $257k 13,534 shares
Last Trade
Aug 08, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.24k 128 shares
$48.75
$19.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up